Nitric oxide (NO) overproduction is correlated with numerous human diseases, such as arthritis, asthma, diabetes, inflammation and septic shock. The enzyme activities of both NO synthase (NOS) and dimethylarginine dimethylaminohydrolase-1 (DDAH-1) promote NO production. DDAH-1 mainly colocalizes in the same tissues as the neuronal isoform of NOS and catabolizes the endogenously-produced competitive inhibitors of NOS, N[omega]-monomethyl-L-arginine (NMMA) and asymmetric N[omega], N[omega]-dimethyl-L-arginine (ADMA). Inhibition of DDAH-1 leads to elevated concentrations of NMMA and ADMA, which subsequently inhibit NOS. To better understand DDAH-1, I first characterized the catalytic mechanism of human DDAH-1, where Cys274, His173, Asp79 and Asp127 form a catalytic center. Particularly, Cys274 is an active site nucleophile and His173 plays a dual role in acid/base catalysis. I also studied an unusual mechanism for covalent inhibition of DDAH-1 by S-nitroso-L-homocysteine (HcyNO), where an N-thiosulfoximide adduct is formed at Cys274. Using a combination of site directed mutagenesis and mass spectrometry, we found that many residues that participate in catalysis also participate in HcyNO mediated inactivation. Following these studies, I then screened a small set of known NOS inhibitors as potential inhibitors of DDAH-1. The most potent of these, an alkylamidine, was selected as a scaffold for homologation. Stepwise lengthening of the alkyl substituent changes an NOS-selective inhibitor into a dual-targeted NOS/DDAH-1 inhibitor then into a DDAH-1 selective inhibitor, as seen in the inhibition constants of N5-(1-iminoethyl)-, N5-(1-iminopropyl)-, N5-(1-iminopentyl)- and N5-(1-iminohexyl)-L-ornithine for neuronal NOS (1.7, 3, 20, >1,900 [mu]M, respectively) and DDAH-1 (990, 52, 7.5, 110 [mu]M, respectively). X-ray crystal structures suggest that this selectivity is likely due to active site size differences. To rank the inhibitors' in vivo potency, we constructed a click-chemistry based activity probe to detect inhibition of DDAH-1 in live mammalian cell culture. In vivo IC50 values for representative alkylamidine based inhibitors were measured in living HEK293T cells. Future application of this probe will address the regulation of DDAH-1 activity in pathophysiological states. In summary, this work identifies a versatile scaffold for developing DDAH targeted inhibitors to control NO overproduction and provides useful biochemical tools to better understand the etiology of endothelial dysfunction. / text

Le monoxyde d’azote (NO), dont le rôle biologique a été découvert à la fin du 20ème siècle, est impliqué dans la régulation de nombreux processus à l’échelle de la cellule et de l’organisme. Sa biosynthèse est réalisée par les enzymes NO synthases (NOS), et met en jeu la liaison de NADPH à leur domaine réductase suivie d’une série de transfert d’électrons vers leur domaine oxygénase, où la formation de NO se produit par oxydation de la L-arginine. En s’inspirant de mimes photo-activables de NADPH précédemment décrits dans la littérature, appelés nano-déclencheurs (NT, de l’anglais nanotriggers), induisant la production de NO par illumination, nous avons conçu et synthétisé de nouvelles générations de composés potentiellement capables d’initier l’activité catalytique de NOS sous irradiation. Ils comportent une unité de reconnaissance de NOS dérivée de l’adénosine et une unité chromophorique de type diaminophényl butadiène, liées entre elles par un groupement triazole. Ces structures modulables, facilement assemblées par chimie « click » ont permis la préparation d’une librairie de nano-déclencheurs, dont les propriétés photophysiques et la stabilité dans des conditions physiologiques ont été évaluées. Ces nouvelles générations de composés offrent des perspectives intéressantes pour le contrôle de processus biologiques par la lumière. / Nitric oxide (NO), whose biological role has been discovered in the late 20th century, is involved in the regulation of many processes in cell and organism. Its biosynthesis is carried out by enzymes named nitric oxide synthases (NOS) and involves NADPH binding to their reductase domain followed by a series of electron transfers to their oxygenase domain, where the formation of NO takes place by oxidation of L-arginine. Inspired by photoactivatable NADPH mimics called nano-triggers (NT), previously described in the literature, able to produce NO upon illumination, we designed and synthesized new generations of compounds potentially capable of initiating the catalytic activity of NOS under irradiation. They contain a recognition unit for NOS derived from adenosine and a diaminophenyl butadiene chromophoric moiety, linked together by a triazole group. These modular structures, easily assembled by "click" chemistry allowed the preparation of a library of nano-triggers, whose photophysical properties and stability under physiological conditions were evaluated. These new generations of compounds offer interesting perspectives for the control of biological processes by light.

No description available.